Clinical Trials

60 enrolled

Down Syndrome, Neoplasms, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01920932 2026-05-06

Adcetris (Brentuximab Vedotin), Combination Chemotherapy, and Radiation Therapy in Treating Younger Patients With Stage IIB, IIIB and IV Hodgkin Lymphoma

77 enrolled 20 charts

Hodgkin Disease, Neoplasms

NCT04546620 2026-04-30

REMoDL-A

453 enrolled

Lymphoma, Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse

NCT03755804 2026-04-23

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

232 enrolled

Hodgkin Disease, Neoplasms

NCT01679119 2026-04-07

INCA

129 enrolled 7 charts

Lymphoma, Large B-Cell, Diffuse

NCT06692452 2026-04-01

Tazemetostat Plus CHOP in 1L T-cell Lymphoma

Phase 2 Withdrawn

Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, T-Cell, Peripheral, Enteropathy-Associated T-Cell Lymphoma

NCT05800366 2026-03-05

A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma

Phase 2 Recruiting

41 enrolled

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT04479267 2025-09-29

Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Previously Untreated Lymphoma

8 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT03899337 2023-01-09

STELLAR

Phase 2 Recruiting

105 enrolled

Lymphoma, Non-Hodgkin, Leukemia, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT05406999 2022-08-16

Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer

Phase 2 Recruiting

900 enrolled

Genitourinary

Neoadjuvant Therapy

NCT01451515 2022-06-28

NHL16: Study For Newly Diagnosed Patients With Acute Lymphoblastic Lymphoma

23 enrolled 14 charts

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03188068 2022-04-21

Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

30 enrolled

Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome

NCT03465527 2022-04-01

Pre-phase Treatment Before R-CHOP Chemotherapy in Elderly Patients With Newly Diagnosed DLBCL

37 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT00637832 2022-01-06

Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma

Phase 2 Terminated

1 enrolled

Lymphoma, Lymphoma, Follicular

NCT01427114 2021-05-06

R-CVP for the Treatment of Non-conjunctival Ocular Adnexal MALT Lymphoma (OAML)

33 enrolled

Lymphoma

NCT04736108 2021-02-08

Neoadjuvant Therapy of Abiraterone Plus ADT for Intraductal Carcinoma of the Prostate

Phase 2 Unknown

50 enrolled

Genitourinary

Prostatic Neoplasms

NCT02890602 2020-02-20

Erythropoietin for Management of Anemia Caused by Chemotherapy

53 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT01074437 2018-10-04

Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)

Phase 2 Terminated

9 enrolled 5 charts

Hemangioma

NCT01719835 2018-03-15

CHEMO-T

Phase 2 Unknown

87 enrolled

Immunoblastic Lymphadenopathy, Lymphoma, T-Cell, Lymphoma, Large-Cell, Anaplastic, Enteropathy-Associated T-Cell Lymphoma

NCT00079105 2017-03-30

A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years

175 enrolled

Hodgkin Disease, Lymphoma

NCT00967226 2016-02-24

Propranolol Versus Prednisolone for Treatment of Symptomatic Hemangiomas

Phase 2 Terminated

19 enrolled 25 charts

Hemangioma

NCT00666484 2014-12-04

Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma

47 enrolled

Hodgkin Disease, Lymphoma, Neurotoxicity Syndromes

NCT00971763 2014-12-04

Gemcitabine Hydrochloride, Cyclophosphamide, Vincristine Sulfate, Prednisolone, and Rituximab in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma

62 enrolled

Lymphoma, Lymphoma, Large B-Cell, Diffuse

NCT00513955 2014-11-05

Combination Chemotherapy With or Without Bortezomib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma

50 enrolled

Lymphoma, Lymphoma, Mantle-Cell

NCT01068392 2014-11-04

Oxaliplatin and Prednisolone (Ox-P) for Patients With Relapsed or Refractory Marginal Zone B-cell Lymphoma(MZL)

42 enrolled

Recurrence, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone

NCT00575406 2013-08-30

NHL-14

94 enrolled

Lymphoma, Large B-Cell, Diffuse

NCT00130195 2008-11-14

Study of Imatinib-Combined Chemotherapy for BCR-ABL-Positive Acute Lymphoblastic Leukemia (ALL)

100 enrolled

Philadelphia Chromosome, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00131053 2008-11-14

Applying Pediatric Regimens to Younger Adult Patients With Acute Lymphoblastic Leukemia (ALL)

Phase 2 Unknown

120 enrolled